Back to Search
HEATHER LYNN MCARTHUR M.D.
M.D.
Medical Oncology Physician
NPI: 1790940385IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
255716(NY)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
255716(NY)C146663(CA)T6640(TX)
Education
UNIVERSITY OF TORONTO, FACULTY OF MEDICINE
Class of 2001
Research & Publications (20)
Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.
PMID 19237634·J Clin Oncol·2009
8-other
An overview of HER-targeted therapy with lapatinib in breast cancer.
PMID 19365626·Adv Ther·2009
6-review
Therapeutic options for metastatic breast cancer.
PMID 19351274·Expert Opin Pharmacother·2009
6-review
Advances in adjuvant chemotherapy of early stage breast cancer.
PMID 18274081·Cancer Treat Res·2008
6-review
Engineered biosynthesis of hybrid macrolide polyketides containing D-angolosamine and D-mycaminose moieties.
PMID 18802638·Org Biomol Chem·2008
8-other
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
PMID 18286526·Cancer·2008
8-other
Adjuvant chemotherapy for early-stage breast cancer.
PMID 17512445·Hematol Oncol Clin North Am·2007
6-review
Has first-line therapy had an impact on general outcome in metastatic breast cancer?
PMID 17661716·Future Oncol·2007
6-review
Current status of the taxanes as adjuvant therapy for breast cancer.
PMID 17723302·Breast·2007
6-review
Dose-dense therapy in the treatment of early-stage breast cancer: an overview of the data.
PMID 18282369·Clin Breast Cancer·2007
6-review
Intravascular hemolysis as a complication of clostridium perfringens sepsis.
PMID 16710038·J Clin Oncol·2006
5-case
Semi-synthetic DNA shuffling of aveC leads to improved industrial scale production of doramectin by Streptomyces avermitilis.
PMID 15721808·Metab Eng·2005
8-other
A novel erythromycin, 6-desmethyl erythromycin D, made by substituting an acyltransferase domain of the erythromycin polyketide synthase.
PMID 12931864·J Antibiot (Tokyo)·2003
8-other
Engineering the aveC gene to enhance the ratio of doramectin to its CHC-B2 analogue produced in Streptomyces avermitilis.
PMID 12599263·Biotechnol Bioeng·2003
8-other
Direct production of ivermectin-like drugs after domain exchange in the avermectin polyketide synthase of Streptomyces avermitilis ATCC31272.
PMID 12968333·Org Biomol Chem·2003
8-other
Biosynthetic origins of the natural product, thiolactomycin: a unique and selective inhibitor of type II dissociated fatty acid synthases.
PMID 12926927·J Am Chem Soc·2003
8-other
Engineering specificity of starter unit selection by the erythromycin-producing polyketide synthase.
PMID 11918808·Mol Microbiol·2002
8-other
Engineering of complex polyketide biosynthesis--insights from sequencing of the monensin biosynthetic gene cluster.
PMID 11774001·J Ind Microbiol Biotechnol·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2201 INWOOD ROAD 3RD FLOOR -- NC3.500
DALLAS, TX 75390 - Phone
- (214) 645-4673
Quick Facts
- NPI
- 1790940385
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 3
- Years in Practice
- 25
- Publications
- 20
Are you this provider?
Claim Your Profile